Novo Nordisk A/S (NVO)

Novo Nordisk Revenue

Novo Nordisk had revenue of 76.86B DKK in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to 311.94B, up 20.90% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

• Revenue (ttm): 311.94B DKK
• Revenue Growth: +20.90%
• P/S Ratio: 5.20
• Revenue / Employee: 4,032,864 DKK
• Employees: 77,349
• Market Cap: 255.49B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.40B	58.14B	25.03%
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.